A lipidated peptide contains a covalently attached lipid-derived group. That description leaves several important questions open: which group, where it attaches, how it is linked and whether other modifications are present. Those details define the molecule and help explain why two lipidated analogues need not behave alike.
Describe the conjugate in connected parts
A useful reading sequence is peptide → attachment site → linker, if present → lipid-derived group. This makes the covalent connection explicit. It differs from adding an unbound lipid to the same solution, which changes the mixture without necessarily creating that conjugate.
Unimod's palmitoylation entry provides one defined example of modification bookkeeping. It records a net C16H30O addition, with monoisotopic mass difference +238.229666 Da, and lists several possible sites. The mass change alone does not state which site or linkage a sample contains.Unimod 47 — Palmitoylation (opens in a new tab)
| Field | Detail to retain |
|---|---|
| Peptide | Sequence, stereochemistry and termini |
| Attachment | Residue number and modified group |
| Linker | Composition and connection pattern |
| Lipid | Chain structure and any additional functional groups |
Position is a structural variable
Imagine two otherwise identical hypothetical peptides bearing the same attached group, one at a terminal amino group and one at a lysine side chain. They share a modification count, but the group occupies a different location. A notation that says only lipidated loses that distinction.
Adding a spacer creates another variable. The spacer is part of the molecule, with its own atoms and geometry; it is not just a line drawn to keep the illustration tidy. Two diagrams should be checked for whether that line represents an explicit chemical linker or merely a graphical connection.
Numbering also needs attention. A position may refer to the parent protein's numbering or to the isolated peptide fragment. Preserve the sequence boundaries so that a stated attachment site can be mapped unambiguously.
One study demonstrates why the details matter
Prada Brichtova and colleagues compared five lipidated GLP-1 analogues differing in attachment position and chemistry. They observed differences in oligomer populations and aggregation behaviour, while lipidation also restricted solubility in their studied systems. These are construct- and condition-specific physical observations.Prada Brichtova and colleagues — Lipidated GLP-1 analogue structures (opens in a new tab)
Several research constructs in that work were C-terminally amidated analogues. Keeping that detail prevents their results from being silently assigned to a differently terminated material with a related name.
A useful summary names the measured property and its comparison. For example, a change in the distribution of oligomers is more precise than a blanket statement that the lipidated molecule is better.
Check what changed alongside the lipid
When comparing a modified and unmodified peptide, inspect the complete structures. If the sequence, linker, terminus and attached group all changed, the experiment compares two complete constructs; it does not automatically isolate the contribution of the lipid alone.
The same applies to calculations. The molecular mass of the final conjugate must include the retained linker and attachment chemistry. Simply adding the mass of a free fatty acid to an unmodified peptide can describe the wrong atom balance.
- Map the stated residue number to the actual sequence.
- Distinguish covalent attachment from a formulation mixture.
- Include the linker and terminal groups in the identity.
- State the particular measured outcome instead of a general benefit.
Sources and further detail
- Unimod 47 — Palmitoylation (opens in a new tab)
Composition change C16H30O, monoisotopic +238.229666 Da. The specificity list includes several attachment sites; a mass shift is not a complete linkage assignment.
- Prada Brichtova and colleagues — Lipidated GLP-1 analogue structures (opens in a new tab)
Author-institution record of Bioconjugate Chemistry 36, 401–414 (2025), DOI 10.1021/acs.bioconjchem.4c00484. Five analogues differ in attachment position and chemistry; several constructs are C-terminally amidated research analogues.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.